HOWL Werewolf Therapeutics, Inc.

NASDAQ
$1.05

Werewolf Therapeutics, Inc. (HOWL) is expected to report earnings on February 11, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +7.1% since its last earnings release on November 13, 2026.

Werewolf Therapeutics Reported Earnings
Friday, November 13, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.02

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Werewolf Therapeutics, Inc.

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.